Revision and validation of the medication adherence self-efficacy scale (MASES) in hypertensive African Americans
- PMID: 18784996
- PMCID: PMC3763496
- DOI: 10.1007/s10865-008-9170-7
Revision and validation of the medication adherence self-efficacy scale (MASES) in hypertensive African Americans
Abstract
Study purpose was to revise and examine the validity of the Medication Adherence Self-Efficacy Scale (MASES) in an independent sample of 168 hypertensive African Americans: mean age 54 years (SD = 12.36); 86% female; 76% high school education or greater. Participants provided demographic information; completed the MASES, self-report and electronic measures of medication adherence at baseline and three months. Confirmatory (CFA), exploratory (EFA) factor analyses, and classical test theory (CTT) analyses suggested that MASES is unidimensional and internally reliable. Item response theory (IRT) analyses led to a revised 13-item version of the scale: MASES-R. EFA, CTT, and IRT results provide a foundation of support for MASES-R reliability and validity for African Americans with hypertension. Research examining MASES-R psychometric properties in other ethnic groups will improve generalizability of findings and utility of the scale across groups. The MASES-R is brief, quick to administer, and can capture useful data on adherence self-efficacy.
Figures
Similar articles
-
Reliability and validity of the Turkish adaptation of medication adherence self-efficacy scale in hypertensive patients.Eur J Cardiovasc Nurs. 2009 Jun;8(2):129-36. doi: 10.1016/j.ejcnurse.2008.10.006. Epub 2008 Nov 28. Eur J Cardiovasc Nurs. 2009. PMID: 19046930
-
A Persian Adaptation of Medication Adherence Self-Efficacy Scale (MASES) in Hypertensive Patients: Psychometric Properties and Factor Structure.High Blood Press Cardiovasc Prev. 2015 Sep;22(3):247-55. doi: 10.1007/s40292-015-0101-8. Epub 2015 May 19. High Blood Press Cardiovasc Prev. 2015. PMID: 25986076
-
Validity of the Turkish version of the medication adherence self-efficacy scale-short form in hypertensive patients.Anadolu Kardiyol Derg. 2012 May;12(3):241-8. doi: 10.5152/akd.2012.068. Epub 2012 Mar 2. Anadolu Kardiyol Derg. 2012. PMID: 22381924
-
Enhancing adherence of antihypertensive regimens in hypertensive African-Americans: current and future prospects.Expert Rev Cardiovasc Ther. 2012 Nov;10(11):1375-80. doi: 10.1586/erc.12.138. Expert Rev Cardiovasc Ther. 2012. PMID: 23244358 Free PMC article. Review.
-
Questionnaires on adherence to antihypertensive treatment: a systematic review of published questionnaires and their psychometric properties.Int J Clin Pharm. 2020 Apr;42(2):355-365. doi: 10.1007/s11096-020-00981-x. Epub 2020 Feb 5. Int J Clin Pharm. 2020. PMID: 32026354
Cited by
-
Factors associated with medication adherence among heart failure patients and their caregivers.J Nurs Educ Pract. 2015;5(3):22-27. doi: 10.5430/jnep.v5n3p22. J Nurs Educ Pract. 2015. PMID: 25635204 Free PMC article.
-
Medication adherence in renal transplant recipients: A latent variable model of psychosocial and neurocognitive predictors.PLoS One. 2018 Sep 28;13(9):e0204219. doi: 10.1371/journal.pone.0204219. eCollection 2018. PLoS One. 2018. PMID: 30265697 Free PMC article.
-
Predictors of β-blocker adherence in cardiac inherited disease.Open Heart. 2018 Dec 16;5(2):e000877. doi: 10.1136/openhrt-2018-000877. eCollection 2018. Open Heart. 2018. PMID: 30613409 Free PMC article.
-
Does Online Community Participation Contribute to Medication Adherence? An Empirical Study of Patients with Chronic Diseases.Int J Environ Res Public Health. 2021 May 12;18(10):5100. doi: 10.3390/ijerph18105100. Int J Environ Res Public Health. 2021. PMID: 34065820 Free PMC article.
-
Development of a measure of self-efficacy for acute headache medication adherence.J Behav Med. 2016 Dec;39(6):1033-1042. doi: 10.1007/s10865-015-9683-9. Epub 2015 Sep 24. J Behav Med. 2016. PMID: 26403506
References
-
- American Heart Association. High Blood Pressure Statistics. [Accessed March 20, 2006.].
-
- Centers for Disease Control and Prevention. Racial/ethnic disparities in prevalence, treatment, and control of hypertension: United States, NHANES 1999–2002. MMWR Morbidity & Mortality Weekly Report. 2005;54:57–59. - PubMed
-
- Hertz RP, Unger AN, Cornell JA, Saunders E. Racial disparities in hypertension prevalence, awareness, and management. Archives of Internal Medicine. 2005;165(18):2098–2104. - PubMed
-
- World Health Organization. Adherence to long-term therapies: Evidence for action. Geneva: World Health Organization; 2003.
-
- Bosworth HB, Dudley T, Olsen MK, et al. Racial differences in blood pressure control: potential explanatory factors. American Journal of Medicine. 2006;119(1):70.e9–70.e15. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical